12 May, 2020

Drug research as an opportunity for Spain

In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal […]
27 April, 2020

Objective: to maintain clinical trials without putting patients’ health at risk

Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that […]
21 April, 2020

New clinical trial designs and more resources for Spain to achieve excellence

Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among […]
20 April, 2020

Spain, a world leader in conducting clinical trials of new drugs

Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract […]
18 March, 2020

Exceptional measures for tests for problems derived from the emergency by COVID-19

Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series […]
9 March, 2020

The pharmaceutical industry warns of the risk of Europe becoming a non-driving, receiving market for innovation

The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
4 March, 2020

The pharmaceutical sector, the basis of a new production model in Spain

Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
24 February, 2020

Create the test that predicts the risk of infection in kidney transplants

Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
10 February, 2020

Drug R&D: increasingly high development costs and lower returns

The expected return on investment in new medicines stands at 1.8%, the lowest point in the last 10 years, according to a Deloitte report On the […]
7 February, 2020

SEFH joins the World Cancer Day recalling the importance of healthy habits and research

Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
6 February, 2020

Clinical research in Spain seeks new impulses to maintain its leadership position in Europe

Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
5 February, 2020

The pharmaceutical industry responds to the increased incidence of cancer: one in two clinical trials focuses on oncology

The impulse to biomedical research in this area allows disease control for longer, increases survival and improves the quality of life of patients The Spanish Agency […]
Private zoneHoja de Validación
Reembolso de Gastos